Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38226 - 38250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	PRAC2	360205	upregulated	entinostat results in increased expression of PRAC2 mRNA	17q21.32	A21035
Entinostat	Investigational	PRDM14	63978	upregulated	entinostat results in increased expression of PRDM14 mRNA	8q13.3	A21037
Entinostat	Investigational	PRDM16	63976	downregulated	entinostat results in decreased expression of PRDM16 mRNA	1p36.32	A21037
Entinostat	Investigational	PRDM5	11107	downregulated	entinostat results in decreased expression of PRDM5 mRNA	4q27	A21035
Entinostat	Investigational	PRELP	5549	upregulated	entinostat results in increased expression of PRELP mRNA	1q32.1	A21035
Entinostat	Investigational	PREPL	9581	upregulated	entinostat results in increased expression of PREPL mRNA	2p21	A21035
Entinostat	Investigational	PRICKLE1	144165	downregulated	entinostat results in decreased expression of PRICKLE1 mRNA	12q12	A21037
Entinostat	Investigational	PRKAA2	5563	upregulated	entinostat results in increased expression of PRKAA2 mRNA	1p32.2	A21035
Entinostat	Investigational	PRKACB	5567	downregulated	entinostat results in decreased expression of PRKACB mRNA	1p31.1	A21035
Entinostat	Investigational	PRKAG2-AS1	100505483	upregulated	entinostat results in increased expression of PRKAG2-AS1 mRNA	7q36.1	A21037
Entinostat	Investigational	PRKCA	5578	upregulated	entinostat results in increased expression of PRKCA mRNA	17q24.2	A21037
Entinostat	Investigational	PRKCB	5579	upregulated	entinostat results in increased expression of PRKCB mRNA	16p12.2-p12.1	A21037 A21035
Entinostat	Investigational	PRKCD	5580	upregulated	entinostat results in increased expression of PRKCD mRNA	3p21.1	A21035
Entinostat	Investigational	PRKCH	5583	upregulated	entinostat results in increased expression of PRKCH mRNA	14q23.1	A21037
Entinostat	Investigational	PRKCQ	5588	upregulated	entinostat results in increased expression of PRKCQ mRNA	10p15.1	A21035
Entinostat	Investigational	PRKD1	5587	downregulated	entinostat results in decreased expression of PRKD1 mRNA	14q12	A21037
Entinostat	Investigational	PRLR	5618	downregulated	entinostat results in decreased expression of PRLR mRNA	5p13.2	A21035
Entinostat	Investigational	PRMT2	3275	downregulated	entinostat results in decreased expression of PRMT2 mRNA	21q22.3	A21037
Entinostat	Investigational	PRMT8	56341	downregulated	entinostat results in decreased expression of PRMT8 mRNA	12p13.32	A21035
Entinostat	Investigational	PRNP	5621	upregulated	entinostat results in increased expression of PRNP mRNA	20p13	A21037
Entinostat	Investigational	PROCR	10544	upregulated	entinostat results in increased expression of PROCR mRNA	20q11.22	A21037 A21035
Entinostat	Investigational	PRODH	5625	upregulated	entinostat results in increased expression of PRODH mRNA	22q11.21	A21037
Entinostat	Investigational	PROK1	84432	upregulated	entinostat results in increased expression of PROK1 mRNA	1p13.3	A21035
Entinostat	Investigational	PROK2	60675	upregulated	entinostat results in increased expression of PROK2 mRNA	3p13	A21035
Entinostat	Investigational	PROS1	5627	downregulated	entinostat results in decreased expression of PROS1 mRNA	3q11.1	A21037

Displaying entries 38226 - 38250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability